Osteoporosis Medications — Types and How They Are Chosen

• There are two main types of bone medication: those that slow bone loss and those that build new bone
• For people at very high fracture risk, experts now recommend building bone first, then protecting it
• Your doctor chooses your medication based on your fracture risk, bone density, age, and overall health
• Treatment is usually long-term — and stopping safely matters just as much as starting

Every medication has both benefits and things to be aware of. Here is a balanced view:

Things to be aware of:

• Every medication carries a small risk of side effects (most are mild)
• Some bone-building medications can only be used for a limited time (12 to 24 months)
• A few treatments require self-injection, which can feel daunting at first
• Stopping certain medications abruptly can cause bone density to drop — always talk to your doctor first

What treatment can do for you:

• Reduce your risk of future fractures — sometimes dramatically
• Improve or maintain your bone density
• Help you stay active, independent, and confident in your daily life

Every medication has trade-offs. Your doctor will work with you to find the best balance for your situation. You are not alone in making this decision.

Think of your bones as a house that is constantly being renovated. Inside your bones, there are two crews always at work: a demolition crew (osteoclasts, which break down old bone) and a construction crew (osteoblasts, which build new bone). In healthy bones, these two crews work in balance. In osteoporosis, the demolition crew has gotten ahead.

Osteoporosis medications work by targeting one or both of these crews:

Bone-building medications (anabolic agents)

These medications energize your construction crew — they stimulate osteoblasts to actively build new bone.

Think of it as hiring extra builders to add new walls, reinforce foundations, and strengthen the structure of your house. These medications do not just slow down bone loss — they actually increase bone mass and improve bone architecture.

Currently available bone-building medications include:

Bone-protecting medications (antiresorptive agents)

These medications calm down the demolition crew — they slow or block the osteoclasts that break down bone.

Think of it as pest-proofing your house — stopping the termites from eating away at the structure. The house does not get bigger, but it is protected from further damage.

Currently available bone-protecting medications include:

Your doctor will recommend a medication based on your bone density results, fracture history, age, and other health conditions. There is no single "best" medication — the best one is the one that fits your situation.

One of the most important advances in osteoporosis treatment is the idea of sequential therapy — using medications in a specific order for the best results.

Here is the key principle:

For people at very high fracture risk (those who have already fractured, have very low bone density, or have multiple risk factors), guidelines from the NOF, AACE, and IOF now recommend:

1. Start with a bone-building medication (teriparatide, abaloparatide, or romosozumab) to rapidly increase bone strength
2. Then switch to a bone-protecting medication (such as a bisphosphonate or denosumab) to lock in those gains

This approach is like first reinforcing your house with new beams and walls, and then applying weatherproofing to make sure it stays strong.

Why not the other way around?

Research has shown that starting with a bone-building medication produces better results than starting with a bone-protecting one and switching later. The NOF Clinician's Guide and AACE/ACE 2020 guidelines both emphasize this "build first, then protect" approach for very high-risk patients.

For patients at moderate risk, starting with a bone-protecting medication (like a bisphosphonate) remains a perfectly good first step.

Your doctor considers several factors when recommending a medication:

• Your fracture risk level — Have you already had a fracture? What does your FRAX score say?
• Your bone density — How low is your T-score?
• Your age and overall health — Are there conditions that make certain medications unsuitable?
• Your preferences and lifestyle — Can you manage daily injections? Do you prefer a once-yearly infusion?
• Other medications you take — Some combinations need to be avoided
• Cost and insurance coverage — Your doctor can help find options that work within your plan

Do not hesitate to ask your doctor: "Why this medication?" and "What are my alternatives?" Understanding your treatment helps you feel confident about it.

Osteoporosis is a chronic condition, much like high blood pressure or diabetes. Treatment is not a short course — it is a long-term commitment to keeping your bones strong.

Important points about treatment duration:

• Bone-building medications are used for a defined period (12 to 24 months) and must be followed by a bone-protecting medication
• Bisphosphonates may be taken for 3 to 5 years, after which your doctor may recommend a "drug holiday" (a monitored pause)
• Denosumab must be continued on schedule — stopping without a transition plan can cause rapid bone loss
• Regular monitoring (bone density scans, blood tests) helps your doctor adjust treatment over time

Stopping treatment on your own — even if you feel fine — can undo the progress you have made. Always talk to your doctor before making changes.

• Ask your doctor which type of medication is right for you and why
• Learn about your specific medication by reading the detailed article for your drug
• Understand that treatment is a journey — the first medication may not be the last, and that is normal
• Keep all your appointments for injections, infusions, and monitoring tests
• Do not stop or skip medication without talking to your doctor first
• Pair medication with lifestyle changes — calcium, vitamin D, exercise, and fall prevention all work together with your medication

Q: Can I just take calcium and vitamin D instead of medication? A: Calcium and vitamin D are important foundations, but for people diagnosed with osteoporosis (especially those who have had fractures), they are not enough on their own. Medications reduce fracture risk in ways that supplements alone cannot.

Q: How long will I need to take bone medication? A: It depends on the medication and your response. Bone-building drugs have a set duration (1 to 2 years). Bisphosphonates are often reviewed after 3 to 5 years. Denosumab is typically continued long-term. Your doctor will reassess regularly.

Q: Are osteoporosis medications safe? A: These medications have been used by millions of people worldwide with a strong safety record. Like all medications, they can have side effects, but for most people, the benefit of preventing fractures far outweighs the risks. Serious side effects are rare.

Q: What if I cannot swallow pills easily? A: There are many alternatives to daily pills — monthly pills, injections every 6 months, or even a once-yearly infusion. Talk to your doctor about what works best for you.

Q: My friend takes a different bone medication than me. Why? A: Treatment is personalized. What is right for one person depends on their fracture risk, bone density, other health conditions, and preferences. The best medication is the one that matches your specific situation.

• National Osteoporosis Foundation (NOF). Clinician's Guide to Prevention and Treatment of Osteoporosis. 2021.
• American Association of Clinical Endocrinology (AACE/ACE). Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis. 2020.
• International Osteoporosis Foundation (IOF). Patient Resources: Treatment of Osteoporosis. 2023.
• Camacho PM, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis. Endocr Pract. 2020;26(Suppl 1):1-46.
• Shoback D, et al. Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update. J Clin Endocrinol Metab. 2020;105(3):587-594.

This site receives founding sponsorship from [sponsor placeholder]. Article content is independently produced by the editorial team with no sponsor involvement. See our conflict of interest policy for details.